Florian Brand

Member of Board of Directors and Founding Seed and Series A Investor

Florian is the Co-Founder and Chief Executive Officer of ATAI Life Sciences AG, a Seed and Series A investor in COMPASS.

Florian focuses on the operational execution of early-stage discovery and drug development programmes. He is currently interim CEO at Perception Neuroscience, one of ATAI’s platform companies. ATAI is a global biotech company builder that leverages a decentralised, technology- and data-driven platform model to serve millions of people suffering with mental health disorders. Prior to ATAI, Florian was Co-founder and MD at Springlane, a growing technology company in the German consumer space. His past experiences include roles at Rocket Internet, Allianz, and the Tanzanian German Program to Support Health. Florian studied economics and management.

We know that the unmet medical need of depression is increasingly urgent. With more than 300 million people living with depression worldwide – a third of whom do not respond to standard treatments – we cannot wait to take action. Together with COMPASS and other leaders in the field, ATAI is committed to bridging the gap between what people living with mental health illnesses need, and what the system can currently provide.